Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia

Elevated serum uric acid is a cardiovascular risk factor in patients with hypertension, even when blood pressure (BP) is well controlled. Xanthine oxidoreductase inhibitors (XORi) reduce serum uric acid levels and have several other potential effects. This multicenter, randomized, open‐label study c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Nishizawa, Masafumi, Kiuchi, Mari, Kiyosue, Arihiro, Tomita, Fumishi, Ohtani, Hiroshi, Abe, Yasuhisa, Kuga, Hideyo, Miyazaki, Satoshi, Kasai, Takatoshi, Hongou, Makiko, Yasu, Takanori, Kuramochi, Jin, Fukumoto, Yoshihiro, Hoshide, Satoshi, Hisatome, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Hyperuricemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029836/
https://www.ncbi.nlm.nih.gov/pubmed/33400348
http://dx.doi.org/10.1111/jch.14153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029836/
https://www.ncbi.nlm.nih.gov/pubmed/33400348
http://dx.doi.org/10.1111/jch.14153

Ejemplares similares